Fortrea Holdings FTRE
NASDAQ FTRE
$18.27 -0.35 (-1.85%)
As of: Sep 4, 2026 · 11:50 AM EDT

Fortrea Holdings (FTRE) Interest Expenses (2022 - 2023)

Fortrea Holdings' (FTRE) quarterly Interest Expenses came in at $9.3 million in Q2 2026, down 22.5% YoY from $12.0 million in Q2 2025, and down 60.26% on a QoQ basis from $23.4 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Interest Expenses (2022 - 2023) Analysis & Trends

Fortrea Holdings (FTRE) has 5 years of Interest Expenses data on file, last reported at $9.3 million in Q2 2026.

  • Quarterly Interest Expenses fell 22.5% year-over-year to $9.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $77.7 million (up 152.27% YoY) and the FY2025 annual result came in at $365.7 million, up 233.67% from the prior year.
  • Interest Expenses declined to $9.3 million in Q2 2026, from $23.4 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $60.1 million in Q2 2023 to a low of -$46.9 million in Q4 2024.
  • A 5-year average of $26.7 million and a median of $27.9 million in 2025 frame the typical range for Interest Expenses.
  • The widest YoY moves for Interest Expenses: up 50000.0% in 2024, down 311.26% in 2024.
  • Tracing FTRE's Interest Expenses over 5 years: stood at $50.5 million in 2022, then tumbled by 56.04% to $22.2 million in 2023, then plunged by 311.26% to -$46.9 million in 2024, then surged by 136.46% to $17.1 million in 2025, then slumped by 45.61% to $9.3 million in 2026.
  • The last three Interest Expenses figures came in at $9.3 million (Q2 2026), $23.4 million (Q1 2026), and $17.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn -1.00 Mn
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - 23.78 Mn
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.63 Bn 27.79 Bn - 93.62 Mn
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn 20.27 Mn
10 Fortrea Holdings 1.73 Bn 1.56 Bn 139.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 34.50 Mn
Sep 30, 2023 34.60 Mn
Jun 30, 2023 700,000.00
Dec 31, 2022 200,000.00